Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study

被引：6
作者：
Ellis, Martin H. [1 ,2 ,3 ]
Dotan, Sari Greenberg [4 ]
Hammerman, Ariel [4 ]
Battat, Erez [4 ]
Derazne, Estela [3 ]
Avnery, Orly [1 ,2 ,3 ]
机构：
[1] Meir Med Ctr, Inst Hematol, Kefar Sava, Israel
[2] Meir Med Ctr, Blood Bank, Kefar Sava, Israel
[3] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel
[4] Clalit Hlth Serv, Tel Aviv, Israel
来源：
THROMBOSIS RESEARCH | 2018年 / 169卷
关键词：
NOAC dose; Atrial fibrillation; Population study; STROKE PREVENTION; NATIONWIDE COHORT; DABIGATRAN; WARFARIN; RIVAROXABAN;
D O I：
10.1016/j.thromres.2018.07.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：140 / 142
页数：3
相关论文
共 10 条
  • [1] [Anonymous], EUR SOC CARD C
  • [2] Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study
    Ellis, Martin H.
    Neuman, Tsipora
    Bitterman, Haim
    Dotan, Sari Greenberg
    Hammerman, Ariel
    Battat, Erez
    Eikelboom, John W.
    Ginsberg, Jeffrey S.
    Hirsh, Jack
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2016, 33 : 55 - 59
  • [3] Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation
    Graham, David J.
    Reichman, Marsha E.
    Wernecke, Michael
    Zhang, Rongmei
    Southworth, Mary Ross
    Levenson, Mark
    Sheu, Ting-Chang
    Mott, Katrina
    Goulding, Margie R.
    Houstoun, Monika
    MaCurdy, Thomas E.
    Worrall, Chris
    Kelman, Jeffrey A.
    [J]. CIRCULATION, 2015, 131 (02) : 157 - 164
  • [4] Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 111 (03) : 381 - 383
  • [5] Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation
    Marzec, Lucas N.
    Wang, Jingyan
    Shah, Nilay D.
    Chan, Paul S.
    Ting, Henry H.
    Gosch, Kensey L.
    Hsu, Jonathan C.
    Maddox, Thomas M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (20) : 2475 - 2484
  • [6] Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    Nielsen, Peter Bronnum
    Skjoth, Flemming
    Sogaard, Mette
    Kjaeldgaard, Jette Nordstrom
    Lip, Gregory Y. H.
    Larsen, Torben Bjerregaard
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [7] Postapproval Observational Studies of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (11): : 1115 - 1116
  • [8] Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study
    Staerk, L.
    Gerds, T. A.
    Lip, G. Y. H.
    Ozenne, B.
    Bonde, A. N.
    Lamberts, M.
    Fosbol, E. L.
    Torp-Pedersen, C.
    Gislason, G. H.
    Olesen, J. B.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2018, 283 (01) : 45 - 55
  • [9] Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes The ORBIT-AF II Registry
    Steinberg, Benjamin A.
    Shrader, Peter
    Thomas, Laine
    Ansell, Jack
    Fonarow, Gregg C.
    Gersh, Bernard J.
    Kowey, Peter R.
    Mahaffey, Kenneth W.
    Naccarelli, Gerald
    Reiffel, James
    Singer, Daniel E.
    Peterson, Eric D.
    Piccini, Jonathan P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (24) : 2597 - 2604
  • [10] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
1